Evidence map›Paper›PMID 37306239›Full record

ArticleInnate immunity2023

Single cell RNA-sequencing of human precision-cut lung slices: A novel approach to study the effect of vaping and viral infection on lung health.

Taylor Crue, Grace Yihua Lee, Joyce Yao-Chun Peng, Niccolette Schaunaman, Hina Agraval, Brian J Day, Kris Genelyn Dimasuay, Diana Cervantes, Hamid Nouri, Taylor Nichols and 4 more

Abstract read
In one paragraph

Article in Innate immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. The triple-hit hypothesis: exploring pulmonary e-cigarette, PMEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  3. Review
  4. mBio · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Taylor CrueDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Grace Yihua LeeSingulomics Corporation, Bronx, NY, USA.
Joyce Yao-Chun PengSingulomics Corporation, Bronx, NY, USA.
Niccolette SchaunamanDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Hina AgravalDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Brian J DayDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Kris Genelyn DimasuayDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Diana CervantesDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Hamid NouriDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Taylor NicholsDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Paige HartsoeDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Mari NumataDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Irina PetracheDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Hong Wei ChuDepartment of Medicine, National Jewish Health, Denver, CO, USA.ORCID 0000-0002-8329-4803

Funding

Tollip inhibits IL-33 signaling during airway influenza virus infectionU19AI125357 · NIAID · UNIVERSITY OF ARIZONA · PI CARR, TARA F · 2016 to 2025
$14.7M
Ceramide-induced Lung Destruction in EmphysemaR01HL077328 · NHLBI · NATIONAL JEWISH HEALTH · PI PETRACHE, IRINA · 2006 to 2024
$8.0M
Parkin in mitochondrial dysfunction and airway inflammation of obese asthmaR01AI152504 · NIAID · NATIONAL JEWISH HEALTH · PI CHU, HONG W, HOLGUIN, FERNANDO · 2020 to 2024
$3.7M
Novel Biased Beta2-AR Ligands as Asthma TherapeuticsR01AI161296 · NIAID · DUKE UNIVERSITY · PI CHU, HONG W, DICKEY, BURTON F · 2021 to 2025
$3.2M
Role of immunoproteasome in airway viral infectionR01AI150082 · NIAID · NATIONAL JEWISH HEALTH · PI CHU, HONG W · 2020 to 2024
$2.8M
Immunosuppressive injurious effects of e-cigarettes on human lung parenchymaR01HL144396 · NHLBI · NATIONAL JEWISH HEALTH · PI CHU, HONG W, PETRACHE, IRINA · 2018 to 2021
$1.9M
NHLBI NIH HHS R01 HL077328NHLBI NIH HHS R01 HL144396NIAID NIH HHS R01 AI150082NIAID NIH HHS R01 AI152504NIAID NIH HHS R01 AI161296NIAID NIH HHS U19 AI125357
6 · The paper itself

Abstract

Vaping is an increasing health threat in the US and worldwide. The damaging impact of vaping on the human distal lung has been highlighted by the recent epidemic of electronic cigarette or vaping use-associated lung injury (EVALI). The pathogenesis of EVALI remains incompletely understood, due to a paucity of models that recapitulate the structural and functional complexity of the human distal lung and the still poorly defined culprit exposures to vaping products and respiratory viral infections. Our aim was to establish the feasibility of using single cell RNA-sequencing (scRNA-seq) technology in human precision-cut lung slices (PCLS) as a more physiologically relevant model to better understand how vaping regulates the antiviral and pro-inflammatory response to influenza A virus infection. Normal healthy donor PCLS were treated with vaping extract and influenza A viruses for scRNA-seq analysis. Vaping extract augmented host antiviral and pro-inflammatory responses in structural cells such as lung epithelial cells and fibroblasts, as well as in immune cells such as macrophages and monocytes. Our findings suggest that human distal lung slice model is useful to study the heterogeneous responses of immune and structural cells under EVALI conditions, such as vaping and respiratory viral infection.

Indexed as

Electronic Nicotine Delivery SystemsLung InjuryVapingVirus DiseasesAntiviral AgentsHumansLungRNAAntiviral AgentsRNAelectronic cigaretteshumanlung slicessingle cell RNA-sequencingvapingviral infection

Identifiers

PMID37306239
PMCPMC10357887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.